Overview of PCDHGA6: Potential Drug Target and Biomarker (G56109)

Target Name: PCDHGA6

NCBI ID: G56109

PCDHGA6

Overview of PCDHGA6: Potential Drug Target and Biomarker

PCDHGA6 (Protocadherin gamma subfamily A, 6, transcript variant 1) is a gene that encodes a protein involved in cell-cell adhesion, which is a critical process in various physiological processes, including development, tissue repair, and embryonic development. The PCDHGA6 protein has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. In this article, we will provide an overview of PCDHGA6, its functions, potential drug targets, and current research on its use as a biomarker.

PCDHGA6 gene and protein

PCDHGA6 is a member of the Protocadherin gene family, which is characterized by the presence of a unique transmembrane domain and a N-terminus that is involved in protein-protein interactions. The PCDHGA6 gene encodes a 144 amino acid protein that has a calculated molecular mass of 17.5 kDa.

The PCDHGA6 protein is involved in the regulation of cell-cell adhesion, which is the process by which cells stick together to form tissues and organs. This process is critical for various physiological functions, including embryonic development, tissue repair, and cancer progression.

PCDHGA6 functions

PCDHGA6 is involved in the regulation of cell-cell adhesion by promoting the interaction between cadherins and various cell surface molecules. This interaction between cadherins and cell surface molecules is critical for the development and maintenance of tissues and organs, including tissues such as skin, heart, and brain.

In addition to its role in cell-cell adhesion, PCDHGA6 is also involved in the regulation of cell proliferation and apoptosis. PCDHGA6 has been shown to play a role in the regulation of cell cycle progression and the execution of cell apoptosis, which is a natural process that helps eliminate damaged or dysfunctional cells.

PCDHGA6 as a drug target

PCDHGA6 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. The PCDHGA6 protein has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

For example, studies have shown that PCDHGA6 is involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, PCDHGA6 has also been shown to be involved in the development and progression of cancer, including breast and ovarian cancer.

PCDHGA6 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This is because the PCDHGA6 protein has been shown to be expressed in various tissues and fluids, including blood, urine, and tissue samples from patients with cancer, neurodegenerative diseases, and developmental disorders.

PCDHGA6 as a biomarker

PCDHGA6 has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This is because the PCDHGA6 protein has been shown to be expressed in various tissues and fluids, including blood, urine, and tissue samples from patients with cancer, neurodegenerative diseases, and developmental disorders.

One of the main advantages of PCDHGA6 as a biomarker is its ability to be easily detected and measured. This is because PCDHGA6 is a protein that is expressed in various tissues and fluids, including blood, urine, and tissue samples from patients. This makes it possible to measure the concentration of PCDHGA6 in these tissues and fluids, which can provide information about the level of PCDHGA6 in the body and its potential role in the development

Protein Name: Protocadherin Gamma Subfamily A, 6

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHGA6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHGA6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets